Yne products Group

Cas No. Product Name MF Assay
943320-61-4 3-Ethynylimidazo[1,2-b]pyridazine C8H5N3 98%min
38002-45-8 3-Bromo-1-(trimethylsilyl)-1-propyne C6H11BrSi 97%+
927-74-2 3-Butyn-1-ol C4H6O 98%min
764-01-2 2-Butyn-1-ol C4H6O 97%min
2028-63-9 3-Butyn-2-ol C4H6O 97%min
13831-03-3 tert-Butyl propiolate C7H10O2 98%min
54060-30-9 3-Aminophenylacetylene C8H7N 99%min
108575-32-2 3-Methylpent-1-yn-3-amine hydrochloride C6H12ClN 98%min
63478-76-2 6-Heptyn-1-ol C7H12O >97%
3034-86-4 Methyl 4-ethynylbenzoate C10H8O2 97%min
434-03-7 Ethisterone;17-alpha-ethynyltestosterone; pregneninolone; C21H28O2 99%min
79887-10-8 4-Pentylphenylacetylene C13H16 >98%
57-63-6 17alpha-Ethynylestradiol C20H24O2 >99%
3973-18-0 Propyne ethoxylate C5H8O2 98%min
2561-17-3 3-Fluorophenylacetylene C8H5F >98%
171290-52-1 3,5-Dimethoxyphenylacetylene C10H10O2 >97%
928-90-5 5-Hexyn-1-ol C6H10O >97%
2450-71-7 Propargylamine C3H5N >98%GC
766-98-3 4-Fluorophenylacetylene C8H5F >98%(GC)
766-49-4 1-Ethynyl-2-fluorobenzene C8H5F >97%
6165-76-0 Propargyl p-toluenesulfonate C10H10O3S 98%HPLC
127-66-2 2-Phenyl-3-butyn-2-ol C10H10O >98%
4298-52-6 2-Ethynylthiophene C6H4S >98%
2975-46-4 3-(Trimethylsilyl)-2-propynal C6H10OSi >95%
766-46-1 2-bromophenylacetylene C8H5Br 97+%
119389-05-8 4-Phenylethynyl phthalic anhydride C16H8O3 >98.5%
1274793 4-Pentyn-1-ol C5H8O >97%
767-91-9 1-Ethynyl-2-methoxybenzene C9H8O 97%min
52670-38-9 2-Ethynylaniline C8H7N 97%min
87205-47-8 D-Propargylglycine C5H7NO2 98%min
72-33-3 Mestranol C21H26O2 97%-102%(w
53293-00-8 Hex-5-ynoic acid C6H8O2 >97%
30964-00-2 6-Heptynoic acid C7H10O2 >98%
623-47-2 Ethyl propiolate C5H6O2 99%min
935-02-4 3-Phenylpropiolonitrile C9H5N 98%min
1057669-91-6 1-Chloro-4-ethynyl-2-nitrobenzene C8H4ClNO2 97%
937-31-5 4-Nitrophenylacetylene C8H5NO2 98%
3032-92-6 4-Ethynylbenzonitrile C9H5N 97%min
14235-81-5 4-Ethynylaniline C8H7N 97%Min
668270-12-0 Linagliptin C25H28N8O2 99%%min
6224-91-5 1-(Trimethylsilyl)propyne C6H12Si 98%min
1271-47-2 Ethynylferrocene C12H12Fe 98%min
1530102 2-(Prop-2-yn-1-yloxy)tetrahydro-2H-pyran C8H12O2 97%min
2345-51-9 But-3-ynoic acid C4H4O2 97%min
79887-16-4 1-Eth-1-ynyl-4-(pentyloxy)benzene C13H16O 97%min
88444-81-9 3',5'-Bis(trifluoromethyl)phenylacetylene C10H4F6 98%min
3355-28-0 1-Bromo-2-butyne C4H5Br 99+%
78-27-3 1-Ethynyl-1-cyclohexanol C8H12O 98+%
590-93-2 2-butynoic acid C4H4O2 98+%
5633-20-5 Oxybutynin C22H31NO3 99+%
183319-69-9 Erlotinib hydrochloride C22H24ClN3O4 99+%
183321-74-6 Erlotinib C22H23N3O4 99+%
92136-39-5 N-Boc-Propargylamine C8H13NO2 98+%
935-14-8 1,4-Diethynylbenzene C10H6 98+%
69088-96-6 4-(3-Aminophenyl)-2-methyl-3-butyn-2-ol C11H13NO 98+% HPLC
84371-65-3 Mifepristone C29H35NO2 99+%
63039-48-5 Boc-L-Propargylglycine C10H15NO4 98+%
5101-44-0 2-Ethynylphenol C8H6O 96+%
1606-85-5 1,4-Bis(2-hydroxyethoxy)-2-butyne C8H14O4 98+%
666816-98-4 8-Bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione C10H9BrN4O2 99+%
4187-87-5 1-Phenylprop-2-yn-1-ol C9H8O 98+%
7567-63-7 1,3,5-Triethynylbenzene C12H6 97+%
108575-32-2 3-AMINO-3-METHYL-1-PENTYNE HYDROCHLORIDE C6H12ClN 98+%
1530250 4-Pentynoic acid C5H6O2 98+%
4341-76-8 Ethyl 2-butynoate C6H8O2 98+%
41105-35-5   1-Chloro-9,10-bis(phenylethynyl)anthracene C30H17Cl 97+%HPLC
871-91-0 7-OCTYN-1-OL C8H14O 97+%
14267-92-6 5-CHLORO-1-PENTYNE C5H7Cl 97+%
762-42-5 Dimethyl acetylenedicarboxylate C6H6O4 98+%
764-93-2 1-Decyne C10H18 96+%
797-63-7 Levonorgestrel;D(minus)-norgestrel; Norgestrel (L-); C21H28O2 99+%
10602-06-9 3-ETHYNYL-BENZOIC ACID METHYL ESTER C10H8O2 97+%



DISCLAIMER:
Products under Patent are not for ultimate sale in the country where patent has not expired. All liability for violation of Patent laws will be to the account of the Purchaser.